Mitchell Chan

Director of Finance/CFO at REGENXBIO INC.

Net worth: 2 M $ as of 2026-06-29

45 year

61 connections

Health Technology

Consumer Services

Commercial Services

Profile

Mitchell Chan is currently Director at Maryland Technology Council since 2020 and Executive VP, Chief Financial & Accounting Officer at REGENXBIO, Inc. starting in 2024.
Former roles include Independent Director at Avalo Therapeutics, Inc. from 2021 to 2026, Operating Partner at Catalio Capital Management LP from 2019 to 2021, Chief Financial & Accounting Officer at Viela Bio, Inc. from 2019 to 2021, and Director-Investor Relations at AstraZeneca PLC from 2015 to 2018.
Education includes an MBA from Rotman School of Management and undergraduate and graduate degrees from the University of Toronto.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
REGENXBIO, INC. 0.25%	2026-01-05	127,717 ( 0.25% )	2 M $	2026-06-29
AVALO THERAPEUTICS INC 0.01%	2026-05-05	3,166 ( 0.01% )	58 508 $	2026-06-29

Mitchell Chan active positions

Companies	Position	Start
REGENXBIO INC.	Director of Finance/CFO	2024-09-15
Maryland Technology Council Maryland Technology Council Miscellaneous Commercial ServicesCommercial Services Function as technology trade association	Director/Board Member	2020-03-10

All active positions of Mitchell Chan

Former positions of Mitchell Chan

Companies	Position	End
AVALO THERAPEUTICS, INC.	Director/Board Member	2026-06-01
VIELA BIO, INC.	Director of Finance/CFO	2021-03-14
Catalio Capital Management LP Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments.	Corporate Officer/Principal	2021-02-28
ASTRAZENECA PLC	Investor Relations Contact	2018-08-31

See the detail of Mitchell Chan's experience

Training of Mitchell Chan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mitchell Chan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
AstraZeneca PLC AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Rotman School of Management Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
REGENXBIO, Inc. REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy	Health Technology
University of Toronto University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Avalo Therapeutics, Inc. Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases	Health Technology
Maryland Technology Council Maryland Technology Council Miscellaneous Commercial ServicesCommercial Services Function as technology trade association	Commercial Services
Viela Bio, Inc. Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for inflammation and autoimmune diseases	Health Technology
Catalio Capital Management LP Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments.	Finance